tiprankstipranks
Trending News
More News >

Bicara Therapeutics price target lowered to $41 from $44 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Bicara Therapeutics (BCAX) to $41 from $44 and keeps a Buy rating on the shares following the Q1 report

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1